PMID: 37416011
This is why healthcare providers use a specific titration schedule, starting you at a low dose and gradually increasing it every four weeks
Approximately 70% of private insurance plans include coverage for semaglutide for diabetes management, making it a more accessible option for many
After 56 weeks: Placebo group lost 1.6% of body weight Starting dose (3.75/23 mg) group lost 5.1% of body weight Top dose (15/92 mg) group lost 10.9% of body weight Beyond weight loss, the CONQUER trial showed significant improvements in blood pressure, waist circumference, lipid profiles, glycemic parameters, and inflammatory biomarkers compared to placebo
In the year since, they say theyve seen a rise in anti-fat content
Before escalating to address a stall, audit protein intake, training volume, and overall caloric intake first